News

Esther Ugwueke is a biomedical expert and PhD student at the University of Nebraska Medical Center, United States, where she ...
In this paper, we investigate several state-of-the-art machine-learning methods for automated classification of clustered microcalcifications (MCs). The classifier is part of a computer-aided ...
However, mammograms during pregnancy may be misleading and potentially harmful. A normal mammogram in the setting of pregnancy does not exclude the possibility of malignancy.
Detection of Microcalcifications in Mammograms Using Support Vector Machine ... The system classifies normal and tumor tissues in addition to benign and malignant tumors. The classification rate was ...
They may seem to appear overnight. Cysts are rarely cancer (malignant). They may be caused by blocked ... They may want to do a mammogram before deciding whether to remove it. These lumps ... These ...
Between 2012 and 2022, incidence rates of breast cancer increased by 1% per year in women older than 50 years and by 1.4% in women younger than 50 years.
AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early detection and prevention.
Not all brain tumours are cancerous! Understand the key differences between benign and malignant brain tumours. Learn from an expert about the symptoms, diagnosis, and treatment options for both ...
Startup Clairity scored a green light from the FDA for the agency's first artificial intelligence tool designed to predict five-year breast cancer risk from a routine screening mammogram.
Medicare covers one baseline mammogram for females between the ages of 35 and 49 years, one yearly screening mammogram for those 40 years or older, and one or more diagnostic mammograms if needed.
BreastScreen Australia now says routine mammograms should include breast density reports but currently only those in New South Wales, Victoria, South Australia and Western Australia do so.
Breast lesions encompass an array of benign and pre-malignant conditions with significant implications for patient management and cancer prevention. Among these, atypical ductal hyperplasia (ADH ...